Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Waverley Pharma (TSE:WAVE)
TSXV:WAVE
Holding TSE:WAVE?
Track your performance easily
WAVE Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.04
Previous CloseC$0.03
Volume7.00K
Average Volume (3M)28.33K
Market Cap
C$1.51M
Enterprise ValueC$3.17M
Total Cash (Recent Filing)C$54.11K
Total Debt (Recent Filing)C$1.72M
Price to Earnings (P/E)―
Beta-0.42
Next Earnings
Aug 23, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding54,000,000
10 Day Avg. Volume3,650
30 Day Avg. Volume28,330
Standard Deviation0.38
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.96
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Waverley Pharma News
PremiumCompany Announcements
Waverley Pharma Welcomes New Director
PremiumCompany Announcements
Waverley Pharma Pivots Strategy Amidst Market ChallengesOptions Prices
Currently, No data available
---
Ownership Overview
73.30%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
26.70% Public Companies and
Individual Investors
WAVE FAQ
What was Waverley Pharma’s price range in the past 12 months?
Waverley Pharma lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Waverley Pharma’s market cap?
Currently, no data Available
When is Waverley Pharma’s upcoming earnings report date?
Waverley Pharma’s upcoming earnings report date is Aug 23, 2024 which is 28 days ago.
How were Waverley Pharma’s earnings last quarter?
Currently, no data Available
Is Waverley Pharma overvalued?
According to Wall Street analysts Waverley Pharma’s price is currently Overvalued.
Does Waverley Pharma pay dividends?
Waverley Pharma does not currently pay dividends.
What is Waverley Pharma’s EPS estimate?
Waverley Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Waverley Pharma have?
Waverley Pharma has 54,000,000 shares outstanding.
What happened to Waverley Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Waverley Pharma?
Currently, no hedge funds are holding shares in TSE:WAVE
---
Waverley Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-66.42%
Trailing 12-Months
Company Description
Waverley Pharma
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide. It is also developing WAV-101 and WAV-102 products for the treatment of cancer. Geographically, it derives revenue from the United Kingdom.
---
Technical Analysis
---